TeleMAb Retrospective Cohort Study
Running, not enrolling
Conditions studied: Medication Abortion, Telemedicine
In brief
The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unscheduled follow-up care in a setting where abortion care, including both virtual and in-person follow-up care, is readily accessible.
Key facts
- Study ID
- NCT07405294
- Run by
- Columbia University
- People needed
- 400
- Starts
- 2023-06-12
- Expected to finish
- 2026-07-31
- Last updated by the study team
- 2026-02-12
Who can join
Age: any. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Received telemedicine or in-person medication abortion at Columbia University Irving Medical Center's associated practices from June 12, 2023 through September 30, 2024
- Gestational age <70 days (based on best obstetrical dating)
- English or Spanish speaking
You may not qualify if…
- Received mifepristone and misoprostol for early pregnancy loss
- Patient determined to have contraindication to medication abortion
- Opted for procedural management instead of medication abortion
- Decided to continue with the pregnancy
- Presenting for a second medication abortion at CUIMC during the study period
- Non-English or Spanish speaking
Where it is running
- Columbia University Irving Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.